Literature DB >> 16007129

The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.

Michaël Jeanblanc1, Marc Mousli, Raphaël Hopfner, Kawtar Bathami, Nadine Martinet, Abdul-Qader Abbady, Jean-Claude Siffert, Eric Mathieu, Christian D Muller, Christian Bronner.   

Abstract

The retinoblastoma protein (pRB) is encoded by the RB1 gene whose promoter contains several putative binding sites for ICBP90 (Inverted CCAAT box Binding Protein of 90 kDa), a transcriptional regulator of the topoisomerase IIalpha gene. ICBP90 has two consensus binding sites for pRB in its primary sequence. Here, we show that pRB and ICBP90 co-immunoprecipitate in cell extracts of proliferating human lung fibroblasts and of proliferating or confluent Jurkat cells. GST pull-down assays and immunocytochemistry, after cell synchronization in late G1 phase, confirmed this interaction. Overexpression of ICBP90 induces downregulation of pRB expression in lung fibroblasts as a result of mRNA decrease. DNA chromatin immunoprecipitation experiment shows that ICBP90 binds to the RB1 gene promoter under its methylated status. Overexpression of ICBP90 increases the S and G2/M phase cell fractions of serum-starved lung fibroblasts as assessed by flow cytometry analysis and increases topoisomerase IIalpha expression. Together, these results show that ICBP90 regulates pRB at the protein and gene transcription levels, thus favoring the entry into the S phase of the cells. We propose that ICBP90 overexpression, found in cancer cells, is involved in the altered checkpoint controls occurring in cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007129     DOI: 10.1038/sj.onc.1208878

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Np95 is implicated in pericentromeric heterochromatin replication and in major satellite silencing.

Authors:  Roberto Papait; Christian Pistore; Diego Negri; Daniela Pecoraro; Lisa Cantarini; Ian Marc Bonapace
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

2.  Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1.

Authors:  Kirsten C Sadler; Katherine N Krahn; Naseem A Gaur; Chinweike Ukomadu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 3.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

4.  Alternative splicing and allosteric regulation modulate the chromatin binding of UHRF1.

Authors:  Maria Tauber; Sarah Kreuz; Alexander Lemak; Papita Mandal; Zhadyra Yerkesh; Alaguraj Veluchamy; Bothayna Al-Gashgari; Abrar Aljahani; Lorena V Cortés-Medina; Dulat Azhibek; Lixin Fan; Michelle S Ong; Shili Duan; Scott Houliston; Cheryl H Arrowsmith; Wolfgang Fischle
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

5.  Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction.

Authors:  Gayathri Rajaraman; Padma Murthi; Niroshani Pathirage; Shaun P Brennecke; Bill Kalionis
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter.

Authors:  Shui-Ping Gao; He-Fen Sun; Liang-Dong Li; Wen-Yan Fu; Wei Jin
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

7.  UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.

Authors:  M Unoki; J D Kelly; D E Neal; B A J Ponder; Y Nakamura; R Hamamoto
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

8.  Prediction of a gene regulatory network linked to prostate cancer from gene expression, microRNA and clinical data.

Authors:  Eric Bonnet; Tom Michoel; Yves Van de Peer
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

9.  Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.

Authors:  J M Pita; A Banito; B M Cavaco; V Leite
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

10.  Evidence that human blastomere cleavage is under unique cell cycle control.

Authors:  Ann A Kiessling; Ritsa Bletsa; Bryan Desmarais; Christina Mara; Kostas Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2009-03-14       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.